Cargando…
Corticosteroids for Graves' Ophthalmopathy: Systematic Review and Meta-Analysis
BACKGROUND: Graves' ophthalmopathy (GO) is a complicated autoimmune disease. Various therapies have been used to manage GO; however the optimum therapy is not clear. Glucocorticoids (GCs) therapy is the mainstay of treatment especially for active moderate to severe patients, which needs evidenc...
Autores principales: | Tu, Xiaofang, Dong, Yan, Zhang, Hongmei, Su, Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282115/ https://www.ncbi.nlm.nih.gov/pubmed/30596092 http://dx.doi.org/10.1155/2018/4845894 |
Ejemplares similares
-
Corticosteroid Pulse Therapy for Graves' Ophthalmopathy Reduces the Relapse Rate of Graves' Hyperthyroidism
por: Le Moli, Rosario, et al.
Publicado: (2020) -
Corticosteroids in Moderate-To-Severe Graves’ Ophthalmopathy: Oral or Intravenous Therapy?
por: Penta, Laura, et al.
Publicado: (2019) -
Autophagy in graves’ ophthalmopathy
por: Chen, Yu-Qing, et al.
Publicado: (2023) -
Monoclonal antibodies for the treatment of Graves’ ophthalmopathy: A systematic review and meta-analysis
por: Fatani, Wed A., et al.
Publicado: (2023) -
Common Immunosuppressive Monotherapy for Graves’ Ophthalmopathy: A Meta-Analysis
por: Mou, Pei, et al.
Publicado: (2015)